MeiraGTx

MGTXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$818.152 M

$8.52 -9.57%

Close of 6 Nov 2026

As of 6 Nov 2026, MeiraGTx (MGTX) has a market capitalization of $818.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$81.4M

#2557 by revenue

Earnings

—

Not reported

Shares outstanding

96,042,996

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#47Odyssey TherapeuticsODTX$904.9M
#48Monte Rosa TherapeuticsGLUE$872.8M
#49MeiraGTxMGTX$818.2M
#50Prime MedicinePRME$806.2M
#51Cullinan TherapeuticsCGEM$704.0M

What if MeiraGTx were worth as much as…

Open the what-if tool →

Gold $28.2T

$294,002.43

Per share 34,513× higher

Bitcoin $1.53T

$15,907.96

Per share 1,867× higher

Apple $5.02T

$52,224.35

Per share 6,131× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for MeiraGTx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.